WE

W. Mark Eickhoff

NL Nano Systems L.L.C.: 6 patents #1 of 47Top 3%
Merck: 5 patents #2,116 of 9,382Top 25%
Eastman Kodak: 2 patents #3,607 of 8,114Top 45%
EI Elan Pharma International: 1 patents #50 of 111Top 50%
Overall (All Time): #305,170 of 4,157,543Top 8%
15
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
12310953 Pharmaceutical formulations for the treatment of migraine Mary Ann Johnson, Leonardo R. Allain, Craig B. Ikeda, Chad D. Brown, Francis J. Flanagan, JR. +6 more 2025-05-27
12220408 Treatment of migraine Mary Ann Johnson, Leonardo R. Allain, Craig B. Ikeda, Chad D. Brown, Francis J. Flanagan, JR. +6 more 2025-02-11
12168004 Treatment of migraine Mary Ann Johnson, Leonardo R. Allain, Craig B. Ikeda, Chad D. Brown, Francis J. Flanagan, JR. +6 more 2024-12-17
11925709 Tablet formulation for CGRP active compounds Mary Ann Johnson, Leonardo R. Allain, Craig B. Ikeda, Chad D. Brown, Francis J. Flanagan, JR. +6 more 2024-03-12
10117836 Tablet formulation for CGRP active compounds Mary Ann Johnson, Leonardo R. Allain, Craig B. Ikeda, Chad D. Brown, Francis J. Flanagan, JR. +6 more 2018-11-06
6432381 Methods for targeting drug delivery to the upper and/or lower gastrointestinal tract Gary Liversidge, Kathleen J. Illig, Pramod Sarpotdar, Stephen B. Ruddy 2002-08-13
5628981 Formulations of oral gastrointestinal diagnostic x-ray contrast agents and oral gastrointestinal therapeutic agents Gary Liversidge, Kathleen J. Illig, Pramod Sarpotdar, Stephen B. Ruddy 1997-05-13
5593657 Barium salt formulations stabilized by non-ionic and anionic stabilizers Stephen B. Ruddy, Gary Liversidge, Mary E. Roberts 1997-01-14
5585108 Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays Stephen B. Ruddy, Gary Liversidge, Eugene R. Cooper 1996-12-17
5580579 Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers Stephen B. Ruddy, Gary Liversidge 1996-12-03
5571536 Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids Karl Mueller, David A. Engers 1996-11-05
5560931 Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids Karl Mueller, David A. Engers 1996-10-01
5518738 Nanoparticulate nsaid compositions David A. Engers, Karl Mueller 1996-05-21
5503723 Isolation of ultra small particles Stephen B. Ruddy 1996-04-02
5466440 Formulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable clays Stephen B. Ruddy, Gary Liversidge, Eugene R. Cooper 1995-11-14